ROCK HILL, South Carolina, June 26, 2025 (GLOBE NEWSWIRE) -- Today, 3D Systems (NYSE: DDD) announced that its 3D bioprinting technologies have enabled FDA approval for the regenerative repair of ...
3D Systems announced FDA approval for a groundbreaking 3D-printed bioabsorbable medical device, COAPTIUM® CONNECT with TISSIUM Light, designed for the repair of peripheral nerve damage. This ...
3D printing may be used to help grow new nerve fibers and restore quality of life for patients living with trigeminal nerve damage, which can cause numbness, tingling, and sudden, severe pain, ...
Researchers at Texas A&M University model extreme conditions using 3D bioprinting, revealing insights that could make flight ...
In associate professor Mauro Tambasco's lab, researchers at all levels work together to develop innovative approaches to fighting cancer.
The rapid advancement of 3D bioprinting technology has revolutionized surgery, medicine, and dentistry. It allows for the creation of customized artificial implants and prosthetics tailored to ...
On November 10, 2025, scientists achieved a significant milestone in the field of biotechnology by 3D printing muscle tissue ...
Instead of making generic parts, 3D printing lets doctors and engineers design medical devices that fit a person’s body ...
Collaboration with French MedTech company, TISSIUM, has resulted in FDA approval for unique 3D-printed polymeric solution for repair of peripheral nerve damage 3D Systems’ bioprinting system enabled ...